You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Express Scripts
McKinsey
Medtronic
Johnson and Johnson

Last Updated: February 26, 2021

DrugPatentWatch Database Preview

METHYLERGONOVINE MALEATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Methylergonovine Maleate, and when can generic versions of Methylergonovine Maleate launch?

Methylergonovine Maleate is a drug marketed by Am Regent, Breckenridge, Amneal Pharms, Granules Pharms, Novel Labs Inc, Teva Pharms Usa, and Tulex Pharms Inc. and is included in seven NDAs.

The generic ingredient in METHYLERGONOVINE MALEATE is methylergonovine maleate. There is one drug master file entry for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the methylergonovine maleate profile page.

US ANDA Litigation and Generic Entry Outlook for Methylergonovine Maleate

A generic version of METHYLERGONOVINE MALEATE was approved as methylergonovine maleate by AM REGENT on November 24th, 2008.

  Start Trial

Drug patent expirations by year for METHYLERGONOVINE MALEATE
Drug Prices for METHYLERGONOVINE MALEATE

See drug prices for METHYLERGONOVINE MALEATE

Recent Clinical Trials for METHYLERGONOVINE MALEATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Brigham and Women's HospitalPhase 4
Johns Hopkins UniversityEarly Phase 1
University of California, San FranciscoPhase 4

See all METHYLERGONOVINE MALEATE clinical trials

Pharmacology for METHYLERGONOVINE MALEATE
Medical Subject Heading (MeSH) Categories for METHYLERGONOVINE MALEATE

US Patents and Regulatory Information for METHYLERGONOVINE MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Am Regent METHYLERGONOVINE MALEATE methylergonovine maleate INJECTABLE;INJECTION 090193-001 Nov 24, 2008 AP RX No No   Start Trial   Start Trial   Start Trial
Tulex Pharms Inc METHYLERGONOVINE MALEATE methylergonovine maleate TABLET;ORAL 212233-001 May 1, 2020 AB RX No No   Start Trial   Start Trial   Start Trial
Granules Pharms METHYLERGONOVINE MALEATE methylergonovine maleate TABLET;ORAL 210424-001 May 15, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Breckenridge METHYLERGONOVINE MALEATE methylergonovine maleate INJECTABLE;INJECTION 040889-001 Sep 13, 2010 AP RX No No   Start Trial   Start Trial   Start Trial
Amneal Pharms METHYLERGONOVINE MALEATE methylergonovine maleate TABLET;ORAL 211483-001 Sep 10, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Express Scripts
McKinsey
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.